In our study, the effect of genistein on SGLT1, GLUT2 and TMPRSS2 expression raises the possibility that it could be a promising agent in reducing postprandial hyperglycaemia and SAR-CoV-2 infection risk. This evidence concerns the gene SLC5A1 and Hyperglycemia.